Free Trial
→ Today's free pick (on me) (From Behind the Markets) (Ad)tc pixel Free NVOS Stock Alerts

Novo Integrated Sciences (NVOS) Competitors

$0.0008 +0.00 (+33.33%)
As of 11:16 AM Eastern
Compare

NVOS vs. BTSGU, BACK, LFMDP, NIVFW, and PIIIW

Should you buy Novo Integrated Sciences stock or one of its competitors? Novo Integrated Sciences's main competitors and comparable companies include BrightSpring Health Services (BTSGU), IMAC (BACK), LifeMD (LFMDP), NewGenIvf Group (NIVFW), and P3 Health Partners (PIIIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Novo Integrated Sciences compare to BrightSpring Health Services?

Novo Integrated Sciences (NASDAQ:NVOS) and BrightSpring Health Services (NASDAQ:BTSGU) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

In the previous week, BrightSpring Health Services had 1 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 1 mentions for BrightSpring Health Services and 0 mentions for Novo Integrated Sciences. BrightSpring Health Services' average media sentiment score of 1.79 beat Novo Integrated Sciences' score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
BrightSpring Health Services Very Positive

BrightSpring Health Services has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A
BrightSpring Health Services$15.25BN/AN/AN/AN/A

BrightSpring Health Services has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. BrightSpring Health Services' return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
BrightSpring Health Services N/A N/A N/A

5.7% of Novo Integrated Sciences shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novo Integrated Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

BrightSpring Health Services beats Novo Integrated Sciences on 7 of the 9 factors compared between the two stocks.

How does Novo Integrated Sciences compare to IMAC?

IMAC (NASDAQ:BACK) and Novo Integrated Sciences (NASDAQ:NVOS) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

In the previous week, IMAC's average media sentiment score of 0.00 equaled Novo Integrated Sciences'average media sentiment score.

Company Overall Sentiment
IMAC Neutral
Novo Integrated Sciences Neutral

IMAC has a beta of 2.2, meaning that its stock price is 120% more volatile than the broader market. Comparatively, Novo Integrated Sciences has a beta of 5.3, meaning that its stock price is 430% more volatile than the broader market.

IMAC has higher earnings, but lower revenue than Novo Integrated Sciences. Novo Integrated Sciences is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K0.00-$9.42M-$3.12N/A
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A

IMAC has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. IMAC's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
Novo Integrated Sciences -121.55%-93.07%-46.28%

5.8% of IMAC shares are owned by institutional investors. Comparatively, 5.7% of Novo Integrated Sciences shares are owned by institutional investors. 12.3% of IMAC shares are owned by insiders. Comparatively, 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

IMAC beats Novo Integrated Sciences on 6 of the 10 factors compared between the two stocks.

How does Novo Integrated Sciences compare to LifeMD?

Novo Integrated Sciences (NASDAQ:NVOS) and LifeMD (NASDAQ:LFMDP) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

LifeMD has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. LifeMD's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
LifeMD N/A N/A N/A

LifeMD has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A
LifeMD$191.59MN/AN/AN/AN/A

5.7% of Novo Integrated Sciences shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, LifeMD had 5 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 5 mentions for LifeMD and 0 mentions for Novo Integrated Sciences. LifeMD's average media sentiment score of 0.56 beat Novo Integrated Sciences' score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
LifeMD Positive

Summary

LifeMD beats Novo Integrated Sciences on 6 of the 8 factors compared between the two stocks.

How does Novo Integrated Sciences compare to NewGenIvf Group?

NewGenIvf Group (NASDAQ:NIVFW) and Novo Integrated Sciences (NASDAQ:NVOS) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

In the previous week, NewGenIvf Group had 1 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 1 mentions for NewGenIvf Group and 0 mentions for Novo Integrated Sciences. NewGenIvf Group's average media sentiment score of 1.82 beat Novo Integrated Sciences' score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company Overall Sentiment
NewGenIvf Group Very Positive
Novo Integrated Sciences Neutral

NewGenIvf Group has higher earnings, but lower revenue than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewGenIvf Group$4.63MN/AN/AN/AN/A
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A

5.7% of Novo Integrated Sciences shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

NewGenIvf Group has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. NewGenIvf Group's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
NewGenIvf GroupN/A N/A N/A
Novo Integrated Sciences -121.55%-93.07%-46.28%

Summary

NewGenIvf Group beats Novo Integrated Sciences on 5 of the 8 factors compared between the two stocks.

How does Novo Integrated Sciences compare to P3 Health Partners?

Novo Integrated Sciences (NASDAQ:NVOS) and P3 Health Partners (NASDAQ:PIIIW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

P3 Health Partners has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A
P3 Health Partners$1.55BN/AN/AN/AN/A

In the previous week, P3 Health Partners had 4 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 4 mentions for P3 Health Partners and 0 mentions for Novo Integrated Sciences. P3 Health Partners' average media sentiment score of 0.79 beat Novo Integrated Sciences' score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company Overall Sentiment
Novo Integrated Sciences Neutral
P3 Health Partners Positive

P3 Health Partners has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. P3 Health Partners' return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
P3 Health Partners N/A N/A N/A

Summary

P3 Health Partners beats Novo Integrated Sciences on 6 of the 8 factors compared between the two stocks.

Get Novo Integrated Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVOS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVOS vs. The Competition

Export
MetricNovo Integrated SciencesHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$16K$10.75B$7.83B$12.01B
Dividend YieldN/A2.54%2.46%4.50%
P/E Ratio0.0035.6434.4130.36
Price / Sales0.002.168.865.82
Price / CashN/A23.6222.2322.80
Price / Book0.003.674.393.77
Net Income-$16.17M$335.01M$3.51B$390.55M
7 Day PerformanceN/A-1.42%-1.68%-0.58%
1 Month PerformanceN/A-1.64%-4.09%-6.84%
1 Year PerformanceN/A19.11%0.66%-6.12%

Novo Integrated Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVOS
Novo Integrated Sciences
N/A$0.00
+33.3%		N/A-92.0%$16K$13.52MN/A170
BTSGU
BrightSpring Health Services
N/A$216.31
-5.9%		N/A+103.9%$0.00$15.25BN/A23,500
BACK
IMAC
N/AN/AN/AN/A$0.00$72.05KN/A180
LFMDP
LifeMD
N/A$21.13
-0.6%		N/A-22.4%$0.00$191.59MN/A384
NIVFW
NewGenIvf Group
N/A$0.01
flat		N/A-17.3%$0.00$4.63MN/A87

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NVOS) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...
Crypto 101 Media | Sponsoredtc pixel